Breast Cancer

Women using the intrauterine system had an increased risk for breast cancer vs. women who were hormonal contraceptive nonusers, according to a research letter published in JAMA.

A voice-activated, in-home cognitive behavioral therapy program alleviated symptoms of insomnia among breast cancer survivors, according to results of a randomized clinical trial.

Hypofractionated radiation therapy after breast cancer surgery significantly reduced risk for adverse events and improved quality of life compared with a conventional radiation therapy schedule, according to study results.

Adults without health insurance in the United States reported they did not have a routine medical visit or cancer screening in the past year, new survey data showed.

Women with breast cancer who began an aerobic exercise program at the start of chemotherapy self-reported improved cognitive function and quality of life, according to results of a randomized trial.

The addition of immune checkpoint inhibitor therapy to neoadjuvant chemotherapy improved pathologic complete response and EFS for certain patients with early-stage breast cancer, according to a systematic review and meta-analysis.

Interest in menopause and all things related to midlife women’s health continues to grow, and The Menopause Society is expanding to meet the demand.

Using a levonorgestrel-releasing intrauterine system device to prevent pregnancy increased risk for breast cancer among women living in Denmark aged 15 to 49 years, according to a research letter published in JAMA.

The FDA accepted a new drug application for elinzanetant, a nonhormonal treatment for moderate to severe vasomotor symptoms associated with menopause, according to an industry press release.

Innovative dosing strategies are warranted to improve the well-being of individuals with metastatic breast cancer, according to a patient advocate-led study published in JCO Oncology Practice.